Prevalence of systemic lupus erythematosus in South Korea: An administrative database study

Journal of Epidemiology

Volumn 24, Issue 4, 2014, Pages 295-303

  Ju, Ji Hyeon ^a   Yoon, Sang Heon ^a,b   Kang, Kwi Young ^a   Kim, In Je ^a   Kwok, Seung Ki ^a   Park, Sung Hwan ^a   Kim, Ho Youn ^a   Lee, Won Chul ^a   Cho, Chul Soo ^a  

^a The Catholic University of Korea   (South Korea)

^b Health Insurance Review Agency   (South Korea)

Author keywords

Epidemiology; Prevalence; Systemic lupus erythematosus

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; FACTUAL DATABASE; FEMALE; HUMAN; MALE; MIDDLE AGED; PREVALENCE; SEX RATIO; SOUTH KOREA; SYSTEMIC LUPUS ERYTHEMATOSUS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; DATABASES, FACTUAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84903946837     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20120204     Document Type: Article

References (23)

1. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25: 1271-7.
2. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
3. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999;42:46-50.
4. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum. 2000;43:1801-8.
5. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol. 2001;13:345-51.
6. Gudmundsson S, Steinsson K. Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. J Rheumatol. 1990;17: 1162-7.
7. Bernatsky S, Joseph L, Pineau CA, Tamblyn R, Feldman DE, Clarke AE. A population-based assessment of systemic lupus erythematosus incidence and prevalence-results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford). 2007;46:1814-8.
8. Bernatsky S, Lix L, Hanly JG, Hudson M, Badley E, Peschken C, et al. Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatol Int. 2011;31: 549-54.
9. Voss A, Green A, Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol. 1998;27:98-105.
10. Williams HJ, Alarcon GS, Joks R, Steen VD, Bulpitt K, Clegg DO, et al. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol. 1999;26:816-25.
11. Lix LM, Yogendran MS, Shaw SY, Burchill C, Metge C, Bond R. Population-based data sources for chronic disease surveillance. Chronic Dis Can. 2008;29:31-8.
12. Jonsson H, Nived O, Sturfelt G, Silman A. Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol. 1990;29:185-8.
13. Ward MM, Pajevic S, Dreyfuss J, Malley JD. Short-term prediction of mortality in patients with systemic lupus erythematosus: classification of outcomes using random forests. Arthritis Rheum. 2006;55:74-80.
14. Katz JN, Barrett J, Liang MH, Bacon AM, Kaplan H, Kieval RI, et al. Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum. 1997;40:1594-600.
15. Lim SS, Jamal A, Bayakly R, Tong L, Drenkard C. Georgia Lupus Registry-accuracy of hospital discharge data in identifying systemic lupus erythematosus [abstract]. Arthritis Rheum. 2007;54 Suppl:S505.
16. Khurma V, Furst DE, Krishnan E, Khanna D. Verification of ICD-CM-9 coding for the diagnosis of systemic sclerosis. Arthritis Rheum. 2006;54 Suppl:S344.
17. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004; 57:131-41.
18. Siegel M, Holley HL, Lee SL. Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. Arthritis Rheum. 1970;13:802-11.
19. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis. 1991;50:490-2.
20. Alarcón GS, McGwin G Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, et al; Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum. 2001;44:2797-806.
21. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995;38:1260-70.
22. Hochberg MC, Perlmutter DL, Medsger TA, Steen V, Weisman MH, White B, et al. Prevalence of self-reported physiciandiagnosed systemic lupus erythematosus in the USA. Lupus. 1995;4:454-6.
23. Nightingale AL, Farmer RD, de Vries CS. Systemic lupus erythematosus prevalence in the U.K.: methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease. Pharmacoepidemiol Drug Saf. 2007;16:144-51.